Trial Details

COMPLETED
Basic Information
Clinical ID c4287
Identifier NCT00741910
Trial Title Extension Study of Semapimod 60 mg IV x 3 Days
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Semapimod
Participant Information
Sponsor Ferring Pharmaceuticals
City Chicago
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2003-07
Primary Completion Date 2006-06
Completion Date 2006-06